Out-of-pocket costs in gastrointestinal cancer patients: Lack of a perfectly framed problem contributing to financial toxicity

Crit Rev Oncol Hematol. 2021 Nov:167:103501. doi: 10.1016/j.critrevonc.2021.103501. Epub 2021 Oct 18.

Abstract

Fighting cancer is an economically expensive challenge for both health care payers, and the patients and their families and the median costs for cancer care are rapidly increasing in the last decade. Although both direct and indirect costs of medical assistance have been a frequent source of distress and contention, however analysis of the non-medical expenses incurred directly by cancer patients has not received adequate attention. Developing a deeper understanding of so-called "out-of-pocket" costs may be necessary. Out-of-pocket costs for medical care range from 7 % to 11 % of medical costs for all payers. However, the range of out-of-pocket costs shows considerable variability in different studies. In this review, we reviewed available data concerning direct and indirect medical costs, including psychosocial ones.

Keywords: Cancer; Costs; Financial toxicity; Out-of-pocket; Therapy.

Publication types

  • Review

MeSH terms

  • Cost of Illness
  • Gastrointestinal Neoplasms*
  • Health Expenditures*
  • Humans
  • Patient Care